Price movement over the last 24 hours
Align Technology, Inc. vs HSBC Holdings plc — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while HSBC Holdings plc trades at $98.3 (market cap $333.00B). The key difference: HSBC Holdings plc is far larger — about 25.9× Align Technology, Inc.'s market cap, and HSBC Holdings plc pays a 3.78% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | HSBC | |
|---|---|---|
Market Cap | $12.86B | $333.00B |
Sector | Health | Technology |
52-Week High | $207.19 | $99.09 |
52-Week Low | $124.88 | $61.30 |
Enterprise Value | $11.92B | — |
Dividend Yield | — | 3.78% |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
HSBC trades at $99.09, up 1.09% today and near its 52-week high of $99.47. The stock shows bullish technical signals with consistent earnings beats in recent quarters. Recent news highlights strategic moves, including a potential Turkey business sale and AI expansion with Google Cloud. Revenue is stable at $71.02B for 2025, with a net income margin of 30.81% and a P/E ratio of 16.38.
Outlook is cautiously optimistic, supported by earnings momentum and restructuring efforts. Risks include regulatory penalties and global economic sensitivity. Analysts are mixed, with 38.1% recommending buy. The dividend of $0.50 per share adds income appeal, but investors should monitor execution of strategic initiatives.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →